{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-058331","form_type":"8-K","ticker":"KTTA","cik":"0001841330","company_name":"Pasithea Therapeutics Corp.","filed_at":"2023-07-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.662681+00:00","generated_at":"2026-06-13T05:46:28.433089+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pasithea announces $4M tender offer for common stock at $0.70/share, expected Q3 2023","bullets":["Board authorized $4.0M tender offer to repurchase up to ~5.7M shares at $0.70 per share in cash.","Tender offer expected to close in the third quarter of 2023.","Executive officers and directors will not tender any shares in the offer.","If oversubscribed, shares will be accepted on a pro rata basis."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-058331","json":"https://secwatch.observer/filing/0001213900-23-058331.json","markdown":"https://secwatch.observer/filing/0001213900-23-058331.md","text":"https://secwatch.observer/filing/0001213900-23-058331.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841330/000121390023058331/0001213900-23-058331-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841330/000121390023058331/ea182059-8k_pasithea.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T05:46:28.433089+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}